Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Real-time Estimate Cboe BZX
Other stock markets
 01:11:57 2024-05-17 pm EDT 		5-day change 1st Jan Change
2.195 USD +1.62% Intraday chart for Acurx Pharmaceuticals, Inc. +10.34% -41.51%
May. 15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
May. 15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ACURX PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+3.70%+10.34%-41.51%-28.66% - 34.18M
Bullish
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. Charts Acurx Pharmaceuticals, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW